RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on ...

Industry veteran Peter C. Wulff joins Glucotrack to drive financial strategy and commercialization of its continuous blood glucose monitor for people with diabetesRUTHERFORD, N.J., Jan. 29, 2025 ...

Nisa Investment Advisors LLC grew its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 973.3% ...

Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Alphatec Holdings , Inc. (NASDAQ:ATEC), a medical device company with a market capitalization of $1.6 billion, saw its CEO Miles Patrick recently execute a sale of 43,459 shares of common stock, ...

Alphatec Holdings, Inc, a medical technology company, designs ... operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access ...

Prior to JenaValve, Mr. Wulff served as the financial corporate officer for medical technology companies including Alphatec Spine Holdings ... strategic vision of the Company,” said Mr. Wulff.

Glucotrack, Inc., a medical technology company specializing in diabetes ... officer for medical technology companies including Alphatec Spine Holdings, Artes Medical, CryoCor and Pure Biosciences.

In a report released today, Matt Miksic from Barclays maintained a Sell rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...